A patient wakes at 3 a.m. with light cramping pains every 25 minutes.

At 7 a.m. she notes a clear gush of fluid and calls her provider.

She arrives at the hospital at 8:30 a.m. and a vaginal exam shows she is 5 cm dilated and 100% effaced.

She continues to labor and at 2 p.m. has an overwhelming need to push.

She delivers a healthy boy at 3:30 p.m., and the placenta at 3:45 p.m. How long was the first stage of labor?

Choice A rationale

The cost of a medication is a logistical consideration, not a scientific or pharmacological basis for its clinical preference during labor. The selection of an analgesic is primarily determined by its therapeutic profile, including efficacy, safety for both mother and fetus, and its mechanism of action, rather than economic factors.

Choice B rationale

The administration route is a clinical characteristic, but it does not explain why these specific drugs are preferred. Butorphanol and nalbuphine are typically administered intravenously or intramuscularly, not orally, to achieve rapid onset and predictable plasma concentrations, which is crucial for managing acute labor pain.

Choice C rationale

These medications, like most opioids, are lipophilic and have low molecular weights, allowing them to readily cross the placental barrier via passive diffusion. This is a significant aspect of their pharmacology. The preference for these specific drugs lies in their partial agonist/antagonist activity, which mitigates some of the risks of fetal respiratory depression.

Choice D rationale

Butorphanol and nalbuphine are synthetic opioid agonist-antagonists. This unique pharmacological profile means they bind to and activate kappa opioid receptors while acting as antagonists or partial agonists at mu opioid receptors. This dual action provides effective pain relief while concurrently limiting the degree of respiratory depression compared to full mu-opioid agonists, making them a safer choice for both mother and fetus during labor. *.

Choice A rationale

Normal fetal heart rate variability indicates a healthy, well-oxygenated fetus with a functioning autonomic nervous system. This is a reassuring pattern and would not be the expected outcome of a fentanyl injection, which is known to depress the central nervous system, leading to a decrease in variability.

Choice B rationale

Early decelerations are a benign physiological response caused by head compression during a contraction. They are characterized by a gradual decrease in heart rate that mirrors the contraction and are not associated with uteroplacental insufficiency or the effects of fentanyl.

Choice C rationale

The administration of a narcotic like fentanyl, a central nervous system depressant, can reduce fetal heart rate variability. Loss of variability coupled with late decelerations is a key indicator of uteroplacental insufficiency, which is a concern after some pain medication administrations and requires immediate intervention to improve fetal oxygenation.

Choice D rationale

Variable decelerations are abrupt decreases in the fetal heart rate caused by umbilical cord compression. The shape, depth, and duration of these decelerations are variable, and they are not typically the primary pattern associated with either uteroplacental insufficiency or the direct central nervous system depressant effects of fentanyl.